Position in BLLN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$14,051,320
-$516,200 QoQ
Shares Held
178,000
0.0% QoQ
Ownership
0.387%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Capital International Investors holds $6,385,693,369 across 7 Diagnostics & Research names. BLLN ranks #7 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
14,014,713 | $2,657,189,584 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
3,888,726 | $1,911,425,490 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
1,080,771 | $1,363,068,385 | |
| 4 | GH |
Guardant Health, Inc.
|
3,481,318 | $321,569,343 | |
| 5 | QGEN |
Qiagen N.V.
|
2,436,169 | $97,544,206 | |
| 6 | WGS |
GeneDx Holdings Corp.
|
324,588 | $20,845,041 | |
| 7 | BLLN |
BillionToOne, Inc.
This page
|
178,000 | $14,051,320 |
All Filings in BLLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,051,320 | 178,000 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $14,567,520 | 178,000 | Shares | Defined | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||